Here are the uncensored but documented facts about monkeypox and the vaccines that the US government is buying up from a little-known company in Denmark that only has five products on the market.

Survival Rate of a Monkeypox (MPOX) Infection Ref: https://ncbi.nlm.nih.gov/pmc/articles/PMC10389550

Globally, the survival rate after getting a monkeypox infection is 99.942%. Of the 80,850 cases of monkeypox that have been documented since 2022, only 55 of them died. And no comorbidities, locations, or possible socioeconomic factors are identified.

The 2024 Global Prevalence Rates Ref: https://ourworldindata.org/mpox

In 2024, the highest single day of reported infections globally was 64. In the latter half of July, the latest statistics show that the global prevalence rate is between 3 and 8 cases per day. That is right across the globe. That is not just in the USA, or the UK, or Australia, or Canada. That is worldwide.

The Vaccine Candidate and Its Known Side Effects Ref: https://fda.gov/media/131078/download

Since the US government has already spent $157 million on buying the JYNNEOS monkeypox vaccines (Ref. https://fiercepharma.com/pharma/bavarian-nordic-scores-1568m-contract-replenish-us-supplies-combination-smallpoxmpox-vaccine#:~:text=Fierce%20Pharma-,Bavarian%20Nordic%20scores%20%24157M%20contract%20to%20replenish,of%20smallpox%2Fmpox%20vaccine%20Jynneos&text=Following%20the%20commercial%20launch%20of,agreement%20with%20the%20U.S.%20government ) from a little-known pharmaceutical company headquartered in Denmark, Bavarian Nordic, which only makes five products, I think it is safe to assume that this is going to be the one that they are going to push down our throats.

The makers admit causal relationships between this vaccine and Crohn's disease, sarcoidosis, extraocular muscle paresis, and throat tightness. However, they list the serious adverse events from their vaccines at 2.3%, which means that the makers themselves admit that 1 in 43 vaccine recipients suffer from serious adverse events. But wait….

Postmarketing experience identified cardiac adverse events of special interest, identifying an additional 1.3% suffering from cardiac-related issues for at least six months post-vaccination. They go further to identify that once again, we are talking about myocarditis and pericarditis in 1 in 77 vaccine recipients.

2.3% + 1.3% = 3.6%, or 1 in every 28 people who received this vaccine, suffered from a serious adverse event because no one thinks that myocarditis and pericarditis are not serious!

All of this is for an infection with a 99.942% survival rate for which the prevalence of infection is at an all-time low while trying to convince us that there is a global concern. Sorry, I am not buying what you are selling.

https://x.com/WitchDrTim/status/1824167542069301374